Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: dose-2 group
Total 0 results
Nothing found
Sponsors and Collaborators
Etwal Ltd.
Enrique Ordiñaga-Monreal, OD, MSc
Ministry of Science and Technology of the People´s Republic of China
Alaska Department of Health and Social Services
Ataturk University SCIENTIFIC RESEARCH PROJECTS COORDINATION UNIT
Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal
University Grants Committee, Hong Kong
The Third People's Hospital of Hubei Province
William Xu, MD
Maryland Treatment Centers @ ARTC
Huan Wang, MD
Academia Sinica, Taiwan
WuHui
NYC RING, Director
Olynka Vega Vega
AdhereTech
The Danish Midwifery Organization
Eva Klappe
Klinik Bad Oexen, Germany
Minnesota Medical Development, Inc.
View Full List
Medical Conditions
Urinary Incontinence in Geriatric Population
Primary Intestinal Lymphangiectasia
Gastric Submucosal Tumors
Food IgE-mediated Allergy
Post-nasal Drip
Infertilities
Cervical Spine Sprain
Advanced Intestinal Cancer
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Human Mammary Carcinoma
Primary Hypomagnesemia (Disorder)
Venetoclax Combined With Azacitidine
Optim Lead Insulation Related Adverse Events
Orthodontics, Corrective, Palatal Expansion Technique
Aneurysmal Subarachnoid Hemorrhage, Familial
Accidental Injuries
Piperacillin, Tazobactam Drug Combination
Chronic Hepatitis C Genotype 1B
Recurrent Pleural Effusions
Musculoskeletal Injury
View Full List
Drug Interventions
Viread 300Mg Tablet
Vitamin D
Extremecare
SD-101
Docetaxel Injection
Ivermectin
Niacin
ASP8825
Peginterferon alfa-2a
2B3-101 50 mg/m2 every 3 weeks
SOF/VEL
Experimental drug: ESK-001
YYC301-1 & YYC301-2 & YYC301-3
Cyclosporine 0.010%
Neem plus propylene glycol plus salicylic acid
Bempedoic Acid 180 MG Oral Tablet
PHA-022121 selected dose
DP001
Urokinase
Peg-Interferon alpha-2b
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Burundi
Contract Research Organizations in Cameroon
Contract Research Organizations in Ghana
Contract Research Organizations in Hungary
Contract Research Organizations in Kosovo
Contract Research Organizations in Mexico
Contract Research Organizations in Montenegro
Contract Research Organizations in Portugal
Contract Research Organizations in Suriname
Contract Research Organizations in Tunisia
Contract Research Organizations in Türkiye
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Qatar
SGS
All CROs in Qatar
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe